| Financial Year |
March 31 2023 |
| Monetary Funds |
482,316,400.33 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
9,463,614.54 |
| Accounts Receivable |
186,545,130.41 |
| Advances to Suppliers |
1,389,824.40 |
| Other Receivables |
10,483,236.30 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
310,180,986.92 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,045,054.31 |
| Total Current Assets |
1,012,853,762.21 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
1,211,757.30 |
| Fixed Assetes |
532,665,419.35 |
| Under-construction Projects |
16,278,780.27 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
101,554,096.78 |
| R&D expenses |
-- |
| Goodwill |
163,627,766.27 |
| Long-Term Deferred and Prepaid Expenses |
1,090,354.59 |
| Deferred Income Tax Assets |
37,412,256.84 |
| Other Non-Current Assets |
15,277,638.31 |
| Sub-Total of Non-Current Assets |
886,681,898.60 |
| Total Assets |
1,899,535,660.81 |
| Short-Term Loans |
567,790,259.71 |
| Trading Financial liabilities |
-- |
| Notes Payable |
18,307,535.70 |
| Accounts Payable |
186,172,147.60 |
| Accounts Received In Advance |
14,780,146.37 |
| Employee Compensation Payable |
12,125,019.92 |
| Taxes Payable |
11,402,401.77 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
8,849,349.25 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
102,834,635.58 |
| Other Current Liabilities |
10,206,964.40 |
| Sub-Total of Current Liabilities |
936,705,911.73 |
| Long-term Loans |
80,100,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
397,208.50 |
| Deferred Income Tax Liabilities |
12,365,029.39 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
101,210,307.55 |
| Total Liabilities |
1,037,916,219.28 |
| Paid-In Capital(Or Share Stock) |
298,610,000.00 |
| Capital Surplus |
525,703,012.27 |
| Surplus Reserve |
27,588,240.76 |
| LESS:Treasury Stock |
133,481,134.93 |
| Undistributed Profits |
129,477,871.56 |
| Minority Stockholder's Interest |
17,870,988.90 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
843,748,452.63 |
| Owner's Equity（Stockholder's Equity） |
861,619,441.53 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,899,535,660.81 |
